Cancer Research UK Cambridge Institute

Cancer Research UK Cambridge Institute
Name	Cancer Research UK Cambridge Institute
Established	2008
Location	Cambridge, England
Parent	University of Cambridge
Director	(see Notable Researchers and Contributions)
Website	(omitted)

Cancer Research UK Cambridge Institute

The Cancer Research UK Cambridge Institute is a biomedical research institute located within the city of Cambridge, England and affiliated with the University of Cambridge. It focuses on translational oncology linking laboratory discoveries to clinical practice at partners such as Addenbrooke's Hospital and collaborates with international centres including the Francis Crick Institute and the Wellcome Sanger Institute. The Institute draws scientists and clinicians from institutions like King's College London, University College London, Imperial College London, University of Oxford, and research funders including Cancer Research UK and the Wellcome Trust.

History

The Institute was developed amid collaborations involving the University of Cambridge, Cancer Research UK, and the Medical Research Council. Planning and construction engaged stakeholders including the Cambridge Biomedical Campus consortium and received visits from dignitaries associated with the Department of Health and Social Care and the UK Research and Innovation landscape. Its formation built on historic Cambridge laboratories such as the Laboratory of Molecular Biology and drew staff from departments like the Department of Oncology, University of Cambridge and the Cambridge Institute for Medical Research. Major milestones included partnerships with the European Molecular Biology Laboratory and strategic interactions with the National Health Service at Addenbrooke's Hospital.

Research Focus and Programmes

Research at the Institute spans basic and translational themes connecting work by groups from Wellcome Centre for Human Genetics and projects allied to the European Cancer Organisation. Programmes emphasize genetics and genomics informed by datasets from the 100,000 Genomes Project and techniques pioneered at the Wellcome Sanger Institute and the European Bioinformatics Institute. Teams investigate tumour microenvironment studies related to discoveries reported by researchers at the Francis Crick Institute and employ single-cell approaches inspired by methods from the Broad Institute and the Max Planck Institute for Molecular Biomedicine. Therapeutic development aligns with clinical trials networks such as the National Institute for Health and Care Research and integrates imaging methods used at the MRC Laboratory of Molecular Biology. Cross-disciplinary initiatives include computational oncology collaborations with the Alan Turing Institute and systems biology partnerships with the European Organisation for Research and Treatment of Cancer.

Facilities and Infrastructure

Laboratory facilities reflect standards established in centres like the Cambridge Biomedical Campus neighbours, incorporating sequencing platforms comparable to those at the Wellcome Sanger Institute and microscopy suites akin to the MRC Laboratory of Molecular Biology. Shared resources include biobanks modelled on collections at the UK Biobank and imaging infrastructure similar to equipment at the Babraham Institute. The Institute's buildings connect to clinical facilities such as Addenbrooke's Hospital and research park resources like the Milner Therapeutics Institute. Computational infrastructure aligns with high-performance computing resources used by the European Bioinformatics Institute and data governance frameworks influenced by the General Data Protection Regulation-era practices across institutions like King's College London.

Academic and Clinical Partnerships

Academic links include longstanding ties to the University of Cambridge faculties, collaborative appointments with the Department of Pathology, University of Cambridge, and cooperative projects with the Cambridge Judge Business School on translational enterprise. Clinical partnerships extend to Cambridge University Hospitals NHS Foundation Trust, multi-centre trials with Royal Marsden Hospital, and consortium work with the Institute of Cancer Research. International collaborations include exchanges with the Dana–Farber Cancer Institute, the MD Anderson Cancer Center, the Memorial Sloan Kettering Cancer Center, and European partners like the Karolinska Institutet and the Institut Gustave Roussy. Industry engagement has involved pharmaceutical partners such as AstraZeneca, GSK, Roche, and biotech firms inspired by models from Cancer Research UK Cambridge Institute peers on the Cambridge Science Park.

Funding and Governance

Funding sources comprise major charities and agencies including Cancer Research UK, the Wellcome Trust, the Medical Research Council, and the National Institute for Health and Care Research. Philanthropic support mirrors gifts managed through entities like the Gatsby Charitable Foundation and foundations connected to the Wolfson Foundation. Governance includes oversight from university bodies such as the University of Cambridge Council and advisory input from councils similar to the Medical Research Council structure and boards resembling those at the Wellcome Trust. Strategic reviews have drawn on expertise from members affiliated with the Royal Society and trustees with links to institutions like the European Research Council.

Notable Researchers and Contributions

Researchers associated through joint appointments, collaborations, or peer networks include scientists and clinicians with connections to the Laboratory of Molecular Biology, Wellcome Sanger Institute, Francis Crick Institute, Institute of Cancer Research, Royal Marsden Hospital, Dana–Farber Cancer Institute, MD Anderson Cancer Center, Memorial Sloan Kettering Cancer Center, Karolinska Institutet, Institut Gustave Roussy, Broad Institute, Max Planck Institute for Molecular Biomedicine, Babraham Institute, Milner Therapeutics Institute, Cambridge Institute for Medical Research, Department of Oncology, University of Cambridge, Department of Pathology, University of Cambridge, Cambridge University Hospitals NHS Foundation Trust, King's College London, University College London, Imperial College London, University of Oxford, Addenbrooke's Hospital, Wellcome Trust, Cancer Research UK, Medical Research Council, National Institute for Health and Care Research, European Bioinformatics Institute, Alan Turing Institute, UK Biobank, European Molecular Biology Laboratory, European Organisation for Research and Treatment of Cancer, Royal Society, Gatsby Charitable Foundation, Wolfson Foundation, AstraZeneca, GSK, Roche, Cambridge Science Park, Cambridge Biomedical Campus, Cambridge Judge Business School, King's College Hospital, Royal London Hospital, St Bartholomew's Hospital, University of Manchester, University of Edinburgh, University of Glasgow, Heidelberg University, University of Tokyo, Peking University, Tsinghua University, University of Melbourne, University of Toronto, McGill University, University of British Columbia, Monash University, Seoul National University, National University of Singapore, ETH Zurich.

Categories: Category:Medical research institutes in the United Kingdom